Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 868, pseudogene (RN7SL868P) is a truncated, non-functional copy of the canonical 7SL RNA gene, present in the human genome as a processed pseudogene generated by retrotransposition[4][2]. While the active 7SL RNA forms a key part of the signal recognition particle (SRP), which directs newly synthesized proteins to the correct cellular location[3][1], RN7SL868P itself is unable to produce a functional RNA or protein product and does not contribute to cellular biology, disease, or therapeutic processes[2][5]. Its existence can complicate molecular biology studies (e.g., PCR assays) due to its sequence similarity to the active gene, but it is not a target for drug development or clinical biomarkers[2]. Key Context: - 7SL RNA is an essential non-coding RNA, but RN7SL868P is a disabled genetic copy and thus a piece of "junk DNA"[2][4]. - Most pseudogenes, including RN7SL868P, do not encode functional proteins or RNAs and have no regulatory or therapeutic roles[2][5]. - The presence of similar pseudogene sequences can cause technical complications in genetic studies, but does not imply biological or medical significance[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 868, pseudogene (RN7SL868P).